Cargando…

Nebivolol in the treatment of chronic heart failure

Nebivolol is a highly selective beta(1)-adrenergic blocker that also enhances nitric oxide bioavailability via the L-arginine-nitric oxide pathway, leading to vasodilation and decreased peripheral vascular resistance. It is marketed in Europe for the treatment of hypertension and heart failure and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Veverka, Angie, L Salinas, Jennifer
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291309/
https://www.ncbi.nlm.nih.gov/pubmed/18078016